LCGC North America
What are the characteristics and relevant considerations for the development and validation of a stability-indicating method?
Luis Collazo-Malave
Advertisement
Articles by Luis Collazo-Malave
LCGC Europe
In the pharmaceutical industry, the demonstration of drug substance (DS) or drug product (DP) stability over the shelf life is an important aspect of the regulatory requirements.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on LCGC International
1
How AI and Machine Learning Are Reshaping Separations Science at HPLC 2026
2
Analytical Solutions for PFAS Testing - Routine to Discovery Analysis in Environmental Samples and Consumer Products
3
HPLC Comparison of Dopamine in Parkinson's Therapy
4
Chromatographic and Mass Spectrometric Screening of Novel Psychoactive Substances in Seized Drug Analysis
5